| Actions en circulation | 70,943,689 shares |
| Actions d'initiés | 25 736 803 shares |
| Participation des initiés | 36,28 % |
| Nombre total d'initiés | 30 |
Indice de confiance des initiés
L'indice de confiance des initiés identifie les entreprises achetées par les initiés.
Il est le résultat d'un modèle quantitatif sophistiqué et multifactoriel qui identifie les entreprises présentant les niveaux les plus élevés de capitalisation d'initiés. Le modèle de notation utilise une combinaison du nombre net d'initiés ayant acheté des actions au cours des 90 derniers jours, du nombre total d'actions achetées en pourcentage du flottant et du nombre total d'actions détenues par les initiés. Le nombre varie de 0 à 100, les chiffres les plus élevés indiquant un niveau d'accumulation supérieur à celui de ses pairs, et 50 étant la moyenne.
Fréquence de mise à jour : Quotidienne
Indice de confiance des dirigeants
L'indice de confiance des dirigeants identifie les entreprises dont les actions sont achetées par des dirigeants d'entreprise.
Par définition, les dirigeants d'entreprise sont des initiés, mais contrairement à d'autres initiés (actionnaires à 10 % et membres du conseil d'administration), les dirigeants travaillent quotidiennement pour l'entreprise et utilisent leur propre argent lorsqu'ils effectuent des opérations (les actionnaires à 10 % et les membres du conseil d'administration sont souvent des gestionnaires de fonds qui gèrent l'argent d'autrui). À ce titre, les opérations d'initiés réalisées par les dirigeants sont beaucoup plus significatives et doivent être traitées de manière appropriée.
Comme l'indice de confiance des initiés, l'indice de confiance des dirigeants est le résultat d'un modèle quantitatif sophistiqué et multifactoriel qui identifie les entreprises présentant les niveaux les plus élevés d'accumulation de dirigeants.
Fréquence de mise à jour : Quotidienne
Principaux indicateurs des initiés
Cette carte montre comment l'entreprise se positionne par rapport à divers indicateurs d'initiés. La position en centile montre comment cette entreprise se situe par rapport aux autres entreprises sur les marchés américains. Une position plus élevée indique une meilleure situation.
Par exemple, il est généralement admis que les achats d'initiés sont un indicateur positif, de sorte que les entreprises dont les achats d'initiés sont plus nombreux se positionnent mieux que celles dont les achats d'initiés sont moins nombreux (ou même les ventes d'initiés).
Pourcentage du flottant acheté par les initiés (position)
-0.003 %( )
9775 out of 11224Le pourcentage du flottant acheté par les initiés est le nombre total d'actions achetées par les initiés moins le nombre total d'actions vendues par les initiés au cours des 90 derniers jours, divisé par le flottant total et multiplié par 100.
Graphique des opérations d'initiés
Les opérations d'initiés de Phathom Pharmaceuticals, Inc. sont présentées dans le graphique suivant. Les initiés sont des dirigeants, des administrateurs ou des investisseurs importants dans une entreprise. En général, il est illégal pour les initiés d'effectuer des opérations d'initiés dans leur entreprise sur la base d'informations matérielles non publiques. Cela ne signifie pas qu'il est illégal pour eux d'effectuer toute transaction dans leurs propres entreprises. Toutefois, ils doivent déclarer toutes les transactions à la SEC au moyen d'un formulaire 4.
Liste d'initiés et indicateurs de rentabilité
Ce tableau présente la liste des initiés connus et est généré automatiquement à partir des dépôts communiqués à la SEC. Outre les noms, le titre le plus récent et la désignation du directeur, du dirigeant ou du propriétaire à 10 %, nous indiquons les dernières participations divulguées. En outre, lorsque cela est possible, nous indiquons les performances historiques des opérations d'initiés. La performance historique des transactions est une moyenne pondérée de la performance des opérations d'achat réelles sur le marché public effectuées par l'initié. Pour plus d'informations sur le mode de calcul, regardez ce webinaire sur YouTube.
See our leaderboard of most profitable insider traders.
| Initié | Profit moyen (%) | Actions détenues |
Fractionnement Ajusté |
|---|---|---|---|
| Steven L Basta President and CEO, Director - [D] [O] | 0 | 0 | |
| Branning Todd P. | 0 | ||
| Robert Charles Breedlove Principal Accounting Officer - [O] | 53 500 | 53 500 | |
| Michael F Cola Director - [D] | 39 798 | 39 798 | |
| Anne Marie Cook Chief Legal Off. & Corp. Sec. - [O] | 0 | 0 | |
| Terrie Curran President and Chief Executive, Director - [D] [O] | 360 465 | 360 465 | |
| Edwards Jonathan S. Director - [D] | 47 984 | 47 984 | |
|
Fhmls Ix, L.l.c.
10% Owner -
|
5 827 415 | 5 827 415 | |
|
Fhmls Ix, L.p.
10% Owner -
|
5 827 415 | 5 827 415 | |
| Heidi Fields Director - [D] | 30 000 | 30 000 |
| Initié | Profit moyen (%) | Actions détenues |
Fractionnement Ajusté |
|---|---|---|---|
|
Frazier Life Sciences IX, L.P.
10% Owner -
|
5 827 415 | 5 827 415 | |
| Guzzo Anthony J. VP, Chief Accounting Officer - [O] | 8 399 | 8 399 | |
| Molly Henderson CFO and CBO - [O] | 89 868 | 89 868 | |
|
Patrick J Heron
10% Owner -
|
5 827 415 | 5 827 415 | |
| Frank Karbe Director - [D] | 67 500 | 67 500 | |
| Aditya Kohli Chief Business Officer - [O] | 1 686 704 | 1 686 704 | |
|
Peter Kolchinsky
10% Owner -
|
3 115 008 | 3 115 008 | |
|
Ventures Management (Jersey) Ltd Medicxi
10% Owner -
|
61 975 | 61 975 | |
| Azmi Nabulsi Chief Operating Officer - [O] | 1 101 869 | 1 101 869 | |
| Asit Parikh Director - [D] | 113 500 | 113 500 |
| Initié | Profit moyen (%) | Actions détenues |
Fractionnement Ajusté |
|---|---|---|---|
|
Ra Capital Management, Llc
10% Owner -
|
3 115 008 | 3 115 008 | |
|
RA Capital Healthcare Fund LP
10% Owner -
|
3 115 008 | 3 115 008 | |
| Theodore R Schroeder Director - [D] | 21 000 | 21 000 | |
|
Shah Rajeev M.
10% Owner -
|
3 115 008 | 3 115 008 | |
| Slavinsky Christopher W. | 0 | ||
| David A Socks Director - [D] | 19 500 | 19 500 | |
| Mark Stenhouse Director - [D] | 30 000 | 30 000 | |
|
Pharmaceutical Co Ltd Takeda
10% Owner -
|
3 755 583 | 3 755 583 | |
|
James N Topper
Director, 10% Owner -
[D]
|
5 933 327 | 5 933 327 | |
|
Tadataka Yamada
Director, 10% Owner -
[D]
|
3 373 408 | 3 373 408 |
Report errors via our new Insider Auditing Tool
Historique des achats d'initiés - Analyse des bénéfices à court terme
Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans PHAT / Phathom Pharmaceuticals, Inc.. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque transaction et les résultats sont théoriques .
Le tableau suivant présente les achats sur le marché public les plus récents qui ne faisaient pas partie d'un plan de trading automatique.
Prix ajusté est le prix ajusté suite au fractionnement. Actions ajustées est le nombre d'actions ajustées suite au fractionnement.
Historique des ventes d'initiés - Analyse des pertes à court terme
Dans cette section, nous analysons l'évitement des pertes à court terme de chaque vente d'initié non planifiée et réalisée sur le marché public dans PHAT / Phathom Pharmaceuticals, Inc.. Un schéma cohérent d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur l'année qui suit chaque transaction, et les résultats sont théoriques .
Le tableau suivant présente les ventes les plus récentes sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Prix ajusté est le prix ajusté suite au fractionnement. Actions ajustées est le nombre d'actions ajustées suite au fractionnement.
Historique des transactions
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
| Date de dépôt |
Date de transaction |
Formulaire | Initié | Libellé | Nom du titre | Code | Direct | Prix d'exercice |
Prix unitaire |
Unités Modifié |
Valeur Modifiée (1K) |
Options restantes |
Actions restantes |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-18 | 2025-07-16 | 4 | Breedlove Robert Charles | PHAT | Common Stock | D | 8,3639 | -1 692 | -14 | 48 392 | ||||
| 2025-06-24 | 3 | Cook Anne Marie | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
| 2025-06-05 | 2025-06-03 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10 500 | 67 500 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 10 500 | 39 798 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 10 500 | 30 000 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | Topper James N | PHAT | Common Stock | D | 10 500 | 42 596 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | Parikh Asit | PHAT | Common Stock | D | 10 500 | 113 500 | ||||||
| 2025-06-05 | 2025-06-03 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 10 500 | 30 000 | ||||||
| 2025-05-23 | 2025-05-21 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,8649 | 3 780 | 15 | 59 403 | ||||
| 2025-05-15 | 2025-05-14 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,3205 | 6 300 | 21 | 55 623 | ||||
| 2025-05-15 | 2025-05-13 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,1637 | 1 120 | 4 | 49 323 | ||||
| 2025-05-13 | 2025-05-12 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,0395 | 12 601 | 38 | 48 203 | ||||
| 2025-05-13 | 2025-05-09 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,6177 | 2 226 | 8 | 35 602 | ||||
| 2025-05-13 | 2025-05-09 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,1928 | 33 376 | 107 | 33 376 | ||||
| 2025-05-08 | 2025-05-07 | 4 | Parikh Asit | PHAT | Common Stock | D | 2,3969 | 5 000 | 12 | 95 500 | ||||
| 2025-05-08 | 2025-05-06 | 4 | Parikh Asit | PHAT | Common Stock | D | 2,6000 | 5 000 | 13 | 90 500 | ||||
| 2025-05-06 | 3 | Breedlove Robert Charles | PHAT | Common Stock | D | 50 084 | ||||||||
| 2025-05-06 | 3 | Breedlove Robert Charles By 401(k) | PHAT | Common Stock | I | 5 108 | ||||||||
| 2025-04-16 | 2025-04-16 | 4 | Schroeder Theodore R | PHAT | Common Stock | D | 21 000 | 21 000 | ||||||
| 2025-04-16 | 3 | Schroeder Theodore R | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
| 2025-04-08 | 2025-04-07 | 4 | Henderson Molly | PHAT | Common Stock | D | 4,5513 | -3 678 | -17 | 89 868 | ||||
| 2025-04-03 | 3 | Basta Steven L | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
| 2025-03-21 | 2024-09-10 | 4 | Parikh Asit | PHAT | Common Stock | D | 11,7200 | 7 500 | 88 | 93 000 | ||||
| 2025-03-17 | 2025-03-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 4,4200 | 10 000 | 44 | 85 500 | ||||
| 2025-03-03 | 2025-02-27 | 4 | Henderson Molly | PHAT | Common Stock | D | 72 000 | 165 546 | ||||||
| 2025-03-03 | 2025-02-27 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 79 200 | 312 590 | ||||||
| 2025-01-23 | 2025-01-21 | 4 | Henderson Molly | PHAT | Common Stock | D | 6,5883 | -6 583 | -43 | 93 546 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 6,5885 | -7 886 | -52 | 233 390 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Curran Terrie | PHAT | Common Stock | D | 6,5877 | -19 109 | -126 | 360 465 | ||||
| 2024-12-20 | 2024-12-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 8,0000 | -1 118 | -9 | 239 303 | ||||
| 2024-12-20 | 2024-12-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,0000 | -1 291 | -10 | 98 156 | ||||
| 2024-12-16 | 2024-12-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,1248 | 10 000 | 81 | 75 500 | ||||
| 2024-12-16 | 2024-12-13 | 4 | KARBE FRANK | PHAT | Common Stock | D | 7,9267 | 12 500 | 99 | 57 000 | ||||
| 2024-07-17 | 2024-07-15 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 11,7200 | -10 901 | -128 | 240 421 | ||||
| 2024-07-17 | 2024-07-15 | 4 | Henderson Molly | PHAT | Common Stock | D | 11,7200 | -4 325 | -51 | 99 447 | ||||
| 2024-07-17 | 2024-07-15 | 4 | Curran Terrie | PHAT | Common Stock | D | 11,7200 | -33 848 | -397 | 377 734 | ||||
| 2024-05-31 | 2024-05-31 | 4 | Henderson Molly | PHAT | Common Stoock | D | 7 500 | 102 763 | ||||||
| 2024-05-31 | 2024-05-31 | 4 | Nabulsi Azmi | PHAT | Common Stoock | D | 7 500 | 249 567 | ||||||
| 2024-05-31 | 2024-05-29 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10,1645 | 25 000 | 254 | 44 500 | ||||
| 2024-05-24 | 2024-05-23 | 4 | Topper James N | PHAT | Common Stock | D | 10 500 | 32 096 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | Parikh Asit | PHAT | Common Stock | D | 10 500 | 65 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 10 500 | 29 298 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-05-24 | 2024-05-23 | 4 | Socks David A | PHAT | Common Stock | D | 10 500 | 19 500 | ||||||
| 2024-04-10 | 2024-04-08 | 4 | Henderson Molly | PHAT | Common Stoock | D | 11,1000 | -3 435 | -38 | 95 263 | ||||
| 2024-03-26 | 2024-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 9,1100 | -16 851 | -154 | 410 784 | ||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Co-Invest IV LP | PHAT | Common Stock | I | 61 975 | ||||||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth I LP | PHAT | Common Stock | I | 3 673 602 | ||||||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 87 267 | ||||||||
| 2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi IV LP | PHAT | Common Stock | I | 3 641 728 | ||||||||
| 2024-01-25 | 2024-01-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 8,1000 | -3 703 703 | -30 000 | 3 755 583 | ||||
| 2024-01-22 | 2024-01-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,7533 | -6 307 | -49 | 98 698 | ||||
| 2023-11-21 | 2023-11-20 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,2415 | -2 127 | -15 | 103 061 | ||||
| 2023-11-08 | 2023-11-08 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,8000 | 2 500 | 20 | 55 000 | ||||
| 2023-11-08 | 2023-11-07 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,7600 | 4 000 | 31 | 52 500 | ||||
| 2023-11-08 | 2023-11-06 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,0400 | 1 000 | 8 | 48 500 | ||||
| 2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,9500 | -11 681 | -105 | 105 188 | ||||
| 2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,8000 | -811 | -6 | 116 869 | ||||
| 2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 22 500 | 117 680 | ||||||
| 2023-11-03 | 2023-11-01 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 32 500 | 242 067 | ||||||
| 2023-11-03 | 2023-11-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 37 500 | 427 171 | ||||||
| 2023-07-21 | 2023-07-14 | 4/A | Henderson Molly | PHAT | Common Stock | D | 25 000 | 95 180 | ||||||
| 2023-07-17 | 2023-07-14 | 4 | Henderson Molly | PHAT | Common Stock | D | 1,0000 | 25 000 | 25 | 95 180 | ||||
| 2023-07-17 | 2023-07-14 | 4 | Curran Terrie | PHAT | Common Stock | D | 200 000 | 389 671 | ||||||
| 2023-07-17 | 2023-07-14 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 110 000 | 209 567 | ||||||
| 2023-06-05 | 2023-06-02 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,4000 | 15 000 | 111 | 47 500 | ||||
| 2023-06-05 | 2023-06-02 | 4 | Henderson Molly | PHAT | Common Stock | D | 11,4121 | -1 960 | -22 | 68 506 | ||||
| 2023-05-30 | 2023-05-25 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 9 000 | 18 798 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Socks David A | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Parikh Asit | PHAT | Common Stock | D | 9 000 | 32 500 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | KARBE FRANK | PHAT | Common Stock | D | 9 000 | 9 000 | ||||||
| 2023-05-30 | 2023-05-25 | 4 | Topper James N | PHAT | Common Stock | D | 9 000 | 21 596 | ||||||
| 2023-05-23 | 2023-05-22 | 4 | Henderson Molly | PHAT | Common Stock | D | 12,8744 | -2 110 | -27 | 70 466 | ||||
| 2023-04-11 | 2023-04-11 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 8,2600 | 10 000 | 83 | 99 567 | ||||
| 2023-04-11 | 2023-04-10 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,5500 | 1 000 | 8 | 23 500 | ||||
| 2023-04-07 | 2023-04-06 | 4 | Curran Terrie | PHAT | Common Stock | D | 7,8199 | 12 919 | 101 | 188 290 | ||||
| 2023-04-07 | 2023-04-06 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,2700 | -3 439 | -25 | 72 576 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,5309 | -2 032 | -17 | 76 015 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 8,5411 | -1 436 | -12 | 175 371 | ||||
| 2023-02-14 | 2023-02-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,7320 | 5 000 | 39 | 22 500 | ||||
| 2023-01-20 | 2023-01-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 45 000 | 89 567 | ||||||
| 2023-01-20 | 2023-01-20 | 4 | Curran Terrie | PHAT | Common Stock | D | 8,1995 | -5 821 | -48 | 176 807 | ||||
| 2023-01-20 | 2023-01-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 97 500 | 182 628 | ||||||
| 2023-01-20 | 2023-01-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 33 000 | 78 047 | ||||||
| 2023-01-12 | 2023-01-12 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,0000 | 5 000 | 35 | 17 500 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Curran Terrie | PHAT | Common Stock | D | 9,6000 | -1 526 | -15 | 83 720 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Henderson Molly | PHAT | Common Stock | D | 9,6000 | -2 159 | -21 | 43 341 | ||||
| 2022-09-02 | 2022-09-01 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 7 500 | 41 971 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 7 500 | 45 500 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 7 500 | 85 246 | ||||||
| 2022-05-27 | 2022-05-25 | 4 | COLA MICHAEL F | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | FIELDS HEIDI | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | Socks David A | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15 000 | 15 000 | |||||
| 2022-05-27 | 2022-05-25 | 4 | KARBE FRANK | PHAT | Stock Option (Right to Buy) | D | 7,40 | 10 000 | 10 000 | |||||
| 2022-05-20 | 2022-05-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 12 000 | 33 378 | ||||||
| 2022-05-20 | 2022-05-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 12 000 | 38 000 | ||||||
| 2022-05-20 | 2022-05-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 12 000 | 76 595 | ||||||
| 2022-05-16 | 2022-05-16 | 4 | Nabulsi Azmi by Trust | PHAT | Common Stock | I | 8,1644 | 20 000 | 163 | 785 700 | ||||
| 2022-05-16 | 2022-05-13 | 4 | Curran Terrie | PHAT | Common Stock | D | 7,4066 | 20 500 | 152 | 64 595 | ||||
| 2022-05-16 | 2022-05-13 | 4 | Henderson Molly | PHAT | Common Stock | D | 6 000 | 26 000 | ||||||
| 2022-05-16 | 2022-05-12 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,0000 | 12 500 | 100 | 12 500 | ||||
| 2022-04-26 | 2022-04-25 | 4 | KARBE FRANK | PHAT | Stock Option (Right to Buy) | D | 13,61 | 20 000 | 20 000 | |||||
| 2022-04-06 | 2022-04-05 | 4 | Henderson Molly | PHAT | Stock Option (Right to Buy) | D | 15,08 | 100 000 | 100 000 | |||||
| 2022-04-06 | 2022-04-05 | 4 | Henderson Molly | PHAT | Common Stock | D | 20 000 | 20 000 | ||||||
| 2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Warrants | D | 0,00 | -7 359 304 | 0 | |||||
| 2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 19,0000 | -18 | -0 | 7 459 286 | ||||
| 2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 7 359 304 | 7 459 304 | ||||||
| 2022-02-18 | 2019-10-29 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 19,0000 | 9 798 | 186 | 9 798 | ||||
| 2022-01-21 | 2022-01-19 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 15,21 | 97 500 | 97 500 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 19 500 | 21 378 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Guzzo Anthony J. | PHAT | Stock Option (Right to Buy) | D | 15,21 | 30 000 | 30 000 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Guzzo Anthony J. | PHAT | Common Stock | D | 6 000 | 8 399 | ||||||
| 2022-01-21 | 2022-01-19 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 15,21 | 206 250 | 206 250 | |||||
| 2022-01-21 | 2022-01-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 41 250 | 44 095 | ||||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Warrants | D | 0,00 | -228 696 | 7 359 304 | |||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 20,8500 | -1 000 000 | -20 850 | 100 000 | ||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 19,0000 | -1 | -0 | 1 100 000 | ||||
| 2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 228 696 | 1 100 001 | ||||||
| 2021-10-08 | 2021-10-08 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,0490 | -2 529 | -81 | 1 211 346 | ||||
| 2021-10-08 | 2021-10-07 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,6639 | -15 471 | -505 | 1 213 875 | ||||
| 2021-09-23 | 2021-09-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,0600 | -4 100 | -131 | 1 229 346 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,3058 | -324 | -11 | 1 233 446 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,7868 | -13 576 | -445 | 1 233 770 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 31,4907 | -13 791 | -434 | 1 247 346 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 30,4704 | -4 209 | -128 | 1 261 137 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 34,05 | 7 500 | 7 500 | |||||
| 2021-07-09 | 2021-07-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0500 | -2 609 | -91 | 871 305 | ||||
| 2021-07-06 | 2021-07-02 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0100 | -100 | -4 | 873 914 | ||||
| 2021-07-06 | 2021-07-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1600 | -8 226 | -289 | 874 014 | ||||
| 2021-06-29 | 2021-06-29 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,0012 | -13 960 | -475 | 1 260 945 | ||||
| 2021-06-29 | 2021-06-28 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,0869 | -156 | -5 | 1 274 905 | ||||
| 2021-06-29 | 2021-06-28 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,0678 | -25 884 | -882 | 1 275 061 | ||||
| 2021-06-29 | 2021-06-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0800 | -370 | -13 | 882 240 | ||||
| 2021-06-29 | 2021-06-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,0700 | -1 250 | -45 | 882 610 | ||||
| 2021-06-29 | 2021-06-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,4600 | -22 881 | -811 | 883 860 | ||||
| 2021-06-25 | 2021-06-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | -10 848 | -381 | 906 741 | ||||
| 2021-06-25 | 2021-06-23 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -200 | -7 | 917 589 | ||||
| 2021-06-23 | 2021-06-22 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -100 | -4 | 917 789 | ||||
| 2021-06-23 | 2021-06-21 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3100 | -9 294 | -328 | 917 889 | ||||
| 2021-06-21 | 2021-06-18 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1300 | -5 398 | -190 | 927 183 | ||||
| 2021-06-21 | 2021-06-17 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0800 | -3 305 | -116 | 932 581 | ||||
| 2021-06-16 | 2021-06-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0600 | -2 826 | -99 | 935 886 | ||||
| 2021-06-11 | 3 | Guzzo Anthony J. | PHAT | Common Stock | D | 804 | ||||||||
| 2021-06-11 | 2021-06-10 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | -2 102 | -74 | 938 712 | ||||
| 2021-06-11 | 2021-06-09 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,2800 | -1 191 | -42 | 940 814 | ||||
| 2021-06-09 | 2021-06-08 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -100 | -4 | 942 005 | ||||
| 2021-06-09 | 2021-06-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0500 | -2 264 | -79 | 942 105 | ||||
| 2021-06-04 | 2021-06-02 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1800 | -4 300 | -151 | 944 369 | ||||
| 2021-06-02 | 2021-06-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,2000 | -3 967 | -144 | 948 669 | ||||
| 2021-06-02 | 2021-06-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5500 | -7 244 | -258 | 952 636 | ||||
| 2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,5500 | -2 104 | -79 | 959 880 | ||||
| 2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,4000 | -2 668 | -97 | 961 984 | ||||
| 2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3700 | -4 133 | -146 | 964 652 | ||||
| 2021-05-28 | 2021-05-27 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,5500 | -2 279 | -86 | 968 785 | ||||
| 2021-05-28 | 2021-05-27 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,9900 | -6 174 | -228 | 971 064 | ||||
| 2021-05-28 | 2021-05-26 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,9200 | -4 889 | -181 | 977 238 | ||||
| 2021-05-28 | 2021-05-26 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,4500 | -7 469 | -272 | 982 127 | ||||
| 2021-05-26 | 2021-05-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,5900 | -548 | -20 | 989 596 | ||||
| 2021-05-26 | 2021-05-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,1600 | -10 399 | -376 | 990 144 | ||||
| 2021-05-26 | 2021-05-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,1000 | -1 683 | -61 | 1 000 543 | ||||
| 2021-05-26 | 2021-05-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5800 | -8 911 | -317 | 1 002 226 | ||||
| 2021-05-24 | 2021-05-21 | 4 | Yamada Tadataka | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | Socks David A | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | COLA MICHAEL F | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | FIELDS HEIDI | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12 500 | 12 500 | |||||
| 2021-05-24 | 2021-05-21 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,7400 | -11 648 | -416 | 1 011 137 | ||||
| 2021-05-24 | 2021-05-20 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1000 | -7 098 | -249 | 1 022 785 | ||||
| 2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,2662 | -305 | -11 | 1 300 945 | ||||
| 2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9340 | -2 278 | -80 | 1 301 250 | ||||
| 2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,7606 | -899 | -30 | 1 303 528 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,3796 | -3 229 | -108 | 1 304 427 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,7836 | -16 020 | -525 | 1 307 656 | ||||
| 2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 31,9557 | -17 269 | -552 | 1 323 676 | ||||
| 2021-05-18 | 2021-05-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -100 | -4 | 1 029 883 | ||||
| 2021-05-14 | 2021-05-13 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3300 | -100 | -4 | 1 029 983 | ||||
| 2021-05-14 | 2021-05-12 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,0600 | -905 | -33 | 1 030 083 | ||||
| 2021-05-14 | 2021-05-12 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3900 | -10 871 | -385 | 1 030 988 | ||||
| 2021-05-11 | 2021-05-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0300 | -1 011 | -35 | 1 041 859 | ||||
| 2021-05-07 | 2021-05-06 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0100 | -202 | -7 | 1 042 870 | ||||
| 2021-05-07 | 2021-05-05 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | -6 936 | -244 | 1 043 072 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 38,5300 | -100 | -4 | 1 050 008 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,4700 | -3 500 | -131 | 1 050 108 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,2100 | -4 690 | -170 | 1 053 608 | ||||
| 2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5000 | -11 070 | -393 | 1 058 298 | ||||
| 2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 39,0600 | -203 | -8 | 1 069 368 | ||||
| 2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 38,4500 | -11 272 | -433 | 1 069 571 | ||||
| 2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,6000 | -3 157 | -119 | 1 080 843 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,8609 | -1 089 | -41 | 765 700 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,0866 | -1 400 | -52 | 766 789 | ||||
| 2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,1535 | -1 968 | -71 | 768 189 | ||||
| 2021-05-04 | 2021-05-03 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,5876 | -5 753 | -222 | 770 157 | ||||
| 2021-05-04 | 2021-05-03 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,8461 | -4 290 | -162 | 775 910 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 38,0302 | -6 795 | -258 | 1 340 945 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 37,3738 | -6 328 | -237 | 1 347 740 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,9698 | -3 359 | -121 | 1 354 068 | ||||
| 2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9605 | -1 400 | -49 | 1 357 427 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 37,1532 | -1 730 | -64 | 1 358 827 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 36,4002 | -7 769 | -283 | 1 360 557 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,6872 | -12 619 | -450 | 1 368 326 | ||||
| 2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,1131 | -785 | -29 | 780 200 | ||||
| 2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,3656 | -4 316 | -157 | 780 985 | ||||
| 2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 35,6645 | -4 252 | -152 | 785 301 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,1411 | -1 742 | -66 | 789 553 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,2766 | -3 405 | -127 | 791 295 | ||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 6,95 | -11 513 | 855 687 | |||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 44,0838 | -1 140 | -50 | 0 | ||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 43,2368 | -10 373 | -448 | 1 140 | ||||
| 2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 6,9500 | 11 513 | 80 | 11 513 | ||||
| 2021-03-15 | 2021-03-11 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 43,7500 | -710 000 | -31 062 | 3 115 008 | ||||
| 2021-03-12 | 2021-03-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,6700 | -500 | -23 | 1 380 945 | ||||
| 2021-03-12 | 2021-03-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,5367 | -731 | -35 | 1 381 445 | ||||
| 2021-03-12 | 2021-03-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,1809 | -41 698 | -1 967 | 1 382 176 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 49,9303 | -1 802 | -90 | 1 423 874 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 49,0203 | -7 844 | -385 | 1 425 676 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,3163 | -2 425 | -117 | 1 433 520 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,2293 | -2 070 | -96 | 794 700 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,1722 | -1 600 | -72 | 796 770 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,7300 | -24 | -1 | 798 370 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,1576 | -4 833 | -223 | 798 394 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 44,5950 | -600 | -27 | 803 227 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,0549 | -1 548 | -71 | 803 827 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,7696 | -3 825 | -175 | 805 375 | ||||
| 2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 44,6967 | -2 084 | -93 | 1 435 945 | ||||
| 2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 43,3461 | -1 881 | -82 | 1 438 029 | ||||
| 2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,5018 | -1 019 | -43 | 1 439 910 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,9901 | -1 417 | -67 | 1 440 929 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,0250 | -7 241 | -333 | 1 442 346 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 45,2652 | -11 482 | -520 | 1 449 587 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,6100 | -18 316 | -872 | 1 461 069 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,0834 | -21 360 | -1 006 | 1 479 385 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,0207 | -5 200 | -239 | 1 500 745 | ||||
| 2021-02-12 | 2020-12-01 | 5 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | -27 000 | 1 505 945 | ||||||
| 2021-02-03 | 2021-02-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 41,1626 | -6 384 | -263 | 809 200 | ||||
| 2021-02-03 | 2021-02-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 40,5087 | -2 700 | -109 | 815 584 | ||||
| 2021-02-03 | 2021-02-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,0881 | -5 416 | -206 | 818 284 | ||||
| 2021-01-29 | 2021-01-28 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 39,11 | 150 000 | 150 000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Branning Todd P. | PHAT | Stock Option (Right to Buy) | D | 39,11 | 60 000 | 60 000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 39,11 | 225 000 | 225 000 | |||||
| 2021-01-13 | 2021-01-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 36,1845 | -20 091 | -727 | 1 532 945 | ||||
| 2021-01-13 | 2021-01-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,7382 | -7 074 | -253 | 1 553 036 | ||||
| 2021-01-13 | 2021-01-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9235 | -12 835 | -448 | 1 560 110 | ||||
| 2021-01-05 | 2020-01-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,7694 | -1 854 | -63 | 823 700 | ||||
| 2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 34,5700 | -100 | -3 | 825 554 | ||||
| 2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,9332 | -7 614 | -258 | 825 654 | ||||
| 2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,0174 | -4 932 | -163 | 833 268 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,0000 | -100 | -4 | 1 572 945 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,4302 | -12 915 | -535 | 1 573 045 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 40,4894 | -35 197 | -1 425 | 1 585 960 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,9900 | -200 | -10 | 1 621 157 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,1900 | -12 954 | -624 | 1 621 357 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,3492 | -13 292 | -629 | 1 634 311 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,2205 | -5 000 | -231 | 1 647 603 | ||||
| 2020-12-03 | 2020-12-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,5700 | -2 995 | -136 | 838 200 | ||||
| 2020-12-03 | 2020-12-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,0500 | -4 307 | -194 | 841 195 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 44,8300 | -1 828 | -82 | 845 502 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 43,9900 | -5 370 | -236 | 847 330 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 40,3605 | -903 | -36 | 1 652 603 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 39,2240 | -3 354 | -132 | 1 653 506 | ||||
| 2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 38,1747 | -2 620 | -100 | 1 656 860 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 43,0700 | -200 | -9 | 1 659 480 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,3114 | -4 601 | -195 | 1 664 081 | ||||
| 2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,2923 | -7 880 | -325 | 1 668 682 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 44,0000 | -100 | -4 | 1 676 562 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,6663 | -5 477 | -234 | 1 676 662 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,9478 | -5 207 | -218 | 1 682 139 | ||||
| 2020-11-03 | 2020-11-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,8294 | -14 500 | -534 | 852 700 | ||||
| 2020-11-03 | 2020-06-25 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 867 200 | 867 200 | ||||||
| 2020-11-03 | 2020-06-25 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | -867 200 | 0 | ||||||
| 2020-07-13 | 2020-07-13 | 4 | Branning Todd P. | PHAT | Stock Option (Right to Buy) | D | 29,43 | 85 000 | 85 000 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 32,20 | 175 000 | 175 000 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 32,20 | 70 000 | 70 000 | |||||
| 2020-06-16 | 2020-06-12 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | -1 456 854 | 5 827 415 | ||||||
| 2020-05-22 | 2020-05-21 | 4 | FIELDS HEIDI | PHAT | Stock Options | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Topper James N | PHAT | Stock Option | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Yamada Tadataka | PHAT | Stock Option | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | COLA MICHAEL F | PHAT | Stock Option | D | 36,85 | 10 000 | 10 000 | |||||
| 2020-04-03 | 2020-04-01 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,8609 | 117 600 | 2 924 | 3 825 008 | ||||
| 2020-03-31 | 2020-03-31 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,5511 | 30 600 | 751 | 3 707 408 | ||||
| 2020-03-31 | 2020-03-27 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,6000 | 30 000 | 738 | 3 676 808 | ||||
| 2020-03-19 | 2020-03-17 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 29,84 | 20 000 | 20 000 | |||||
| 2020-02-06 | 3/A | Shah Rajeev M. | PHAT | Common Stock | I | 3 646 808 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7 293 292 | ||||||||
| 2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Convertible Promissory Notes | D | 0 | |||||||
| 2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | 19,0000 | 1 052 631 | 20 000 | 7 284 269 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | 15,2000 | 1 353 640 | 20 575 | 6 231 638 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Convertible Promissory Notes | I | 15,20 | 0 | ||||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Convertible Promissory Notes | I | 15,20 | 0 | ||||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 19,0000 | 24 426 | 464 | 47 984 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Common Stock | I | 19,0000 | 1 028 205 | 19 536 | 2 019 877 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 15,2000 | 23 558 | 358 | 23 558 | ||||
| 2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Common Stock | I | 15,2000 | 991 672 | 15 073 | 991 672 | ||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9 755 996 | ||||||||
| 2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1 734 400 | ||||||||
| 2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1 734 400 | ||||||||
| 2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1 734 400 | ||||||||
| 2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3 373 408 | ||||||||
| 2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2 168 000 | ||||||||
| 2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2 168 000 | ||||||||
| 2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2 168 000 | ||||||||
| 2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3 373 408 | ||||||||
| 2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1 686 704 | ||||||||
| 2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1 686 704 | ||||||||
| 2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1 686 704 |
P
Achat sur le marché public ou privé d'un titre non dérivé ou dérivé
S
Vente sur le marché public ou privé d'un titre non dérivé ou dérivé
A
Attribution, récompense ou autre acquisition de titres de l'entreprise (comme une option).
C
Conversion d'un produit dérivé
D
Vente ou transfert de titres à l'entreprise
F
Paiement du prix d'exercice ou de la dette fiscale en utilisant une partie des titres reçus de l'entreprise
G
Don de titres par ou à l'initié
K
Swaps d'actions et opérations de couverture similaires
M
Exercice ou conversion d'un titre dérivé reçu de l'entreprise (tel qu'une option)
V
Une transaction déclarée volontairement sur le formulaire 4
J
Autre (accompagnée d'une note de bas de page décrivant la transaction)
